# Cardiff Oncology, Inc.: Form 8-K, filed Jan 6, 2025

- Company: [Cardiff Oncology, Inc.](/companies/crdf.md) (CIK 1213037)
- Form: 8-K
- Filed: 2025-01-06
- Accepted by EDGAR: Jan 6, 2025, 16:10 ET
- Period: 2025-01-03
- Accession: 0000950170-25-002076
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1213037/000095017025002076/crdf-20250103.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1213037/000095017025002076/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1213037/000095017025002076/crdf-20250103.htm

Filed Jan 6, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-002076. Last ingested by Listed: Nov 13, 2026, 16:10 ET. No prices; not investment advice.
